The Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet and the risk of cancer, cardiovascular diseases, hypertension, all-cause, and cardiovascular diseases mortality: a systematic review and meta-analysis of observational studies

Nutr Metab (Lond). 2026 May 14. doi: 10.1186/s12986-026-01135-y. Online ahead of print.ABSTRACTBACKGROUND: Recent studies have focused on the relationship between the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet and the risk of chronic diseases and mortality. The present s

H Hamid Ahmadirad

Human whole-blood NAD+ levels do not vary with age or lifestyle interventions

Nicotinamide adenine dinucleotide (NAD^(+)) levels in blood and tissues are widely proposed to decline with age, yet evidence in human blood is inconsistent. Using a rigorously validated ultra-high-performance liquid chromatography coupled with high-resolution mass spectrometry system that accounts

M Maria M Trętowicz

Cuffless hemodynamic monitoring with physics-informed machine learning models

Nat Commun. 2026 May 14. doi: 10.1038/s41467-026-72693-1. Online ahead of print.ABSTRACTWearable technologies have the potential to transform ambulatory and at-home hemodynamic monitoring by providing continuous assessments of cardiovascular health metrics and guiding clinical management. However, e

H Henry Crandall

It's time to test all adults for lipoprotein(a)

J Clin Lipidol. 2026 Apr 27:S1933-2874(26)00126-1. doi: 10.1016/j.jacl.2026.04.022. Online ahead of print.ABSTRACTThe recent 2026 American College of Cardiology/American Heart Association Multisociety Guideline on the Management of Dyslipidemia joins the growing international consensus that lipoprot

M Michael J Wilkinson

Intracoronary imaging for left main percutaneous coronary intervention: a clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC and the European Bifurcation Club (EBC)

Eur Heart J. 2026 May 15:ehag353. doi: 10.1093/eurheartj/ehag353. Online ahead of print.ABSTRACTLeft main disease represents one of the most complex lesion subsets for percutaneous coronary intervention, associated with an increased risk of serious late complications. The recent endorsement of intra

T Thomas W Johnson